Talimogene laherparepvec: Phase Ib/II data

Data from 18 patients with previously untreated, unresectable stage IIIB-IV melanoma in the Phase Ib portion of an open-label, U.S. Phase Ib/II trial showed that intratumoral talimogene laherparepvec ...